Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Uses & Benefits
Combinational therapy for type 2 diabetes: Empalina merges two agents—empagliflozin (SGLT2 inhibitor) and linagliptin (DPP-4 inhibitor)—that work through complementary mechanisms to control blood glucose.
Bissoy
Enhanced glycemic control: Recommended as an adjunct to diet and exercise for better blood sugar regulation when monotherapy isn’t enough.
Cardiovascular benefit potential: Empagliflozin has demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease, though this specific combination hasn’t been proven for that outcome.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5